Posts Tagged with:

MaxCyte

HGP – MaxCyte Set to Join Russell 2000® Index

September 17, 2021 | Read more >

HGP – MaxCyte Announces Strategic Immuno-Oncology Collaboration to Advance New Generation of CAR-based Cell Therapies

January 13, 2017 | Read more >

HGP – MaxCyte, NIH NIAID Study Published in Science Translational Medicine Demonstrates CRISPR-Cas9 Repair of X-linked Chronic Granulomatous Disease (CGD) Gene

| Read more >